Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Jan 2015 update from Fluge & Mella on Norwegian rituximab trial

Discussion in 'Rituximab: News and Research' started by Sasha, May 28, 2015.

  1. Sasha

    Sasha Fine, thank you

    jeff_w likes this.

See more popular forum discussions.

Share This Page